Atossa Therapeutics, Inc. (ATOS) Q3 2023 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good morning everyone and thanks for joining us this morning. So I'm joined today with Paul who will talk, who will follow me and as well with Nordin and Philippe that you all know who will intervene during the Q&A session. So thanks for all of them to be here today. So I'm going to start to give you a brief introduction. I will then over to Paul as I said to take through you through the group and business performance in the quarter. And then we'll open for the questions. So first of all, a bit some key takeaway. Well, as you know, I just joined recently after 30 years in the technology sector. And I've seen first-hand Atos technological capability, but as well the highly talented team, the leadership and all team across the globe. So since I joined Atos earlier this month, I've been really impressed by the total commitment and dedication of everyone of Atos to deliver the plan every day with clients and their team. So what I did is that I spent time to better understand our operation, first at Tech Foundation with all infrastructure, digital workplace, and all the other strategic services that they do today, but also with Eviden across digital cloud, digital security, and advanced computing. So for me, it is extremely clear that the business has significant opportunity to capitalize on their strong position across many strategic areas that are extremely differentiated and sometimes unique. So obviously, why focusing on the operation performance and commercial momentum? As we already communicated, we anticipate a shareholder meeting to take place early Q2 2024. We have an investor day to occur slightly before. And finally, I want to insist that we are fully committed to an ongoing open dialogue with all of our shareholders, obviously with all of you today. So now let...